Advertisement

Topics

Cell>Point Company Profile

03:06 EST 14th December 2018 | BioPortfolio

Cell>Point is a clinical-stage biopharmaceutical company developing universal molecular imaging agents and molecular therapeutics for the diagnosis, treatment and treatment monitoring of cancer, heart, and other diseases. Cell>Point has exclusive license to five drug-development platforms, all from The University of Texas M. D. Anderson Cancer Center in Houston, a world leader in cancer research and care. Information on Cell>Point’s drug candidates, recent press releases, and patents and patent filings can be obtained through its website at www.cellpointweb.com. The company is headquartered in Centennial, Colo., and has additional offices in San Francisco and Houston.


News Articles [1376 Associated News Articles listed on BioPortfolio]

Torque Introduces High-efficiency T cell Manufacturing Process

Slipstream operates as modular "compact factories" with the potential to move cell manufacturing closer to point of care

Old Point Releases Second Quarter 2018 Results

HAMPTON, Va., July 27, 2018 /PRNewswire/ -- Old Point Financial Corporation (the Company or Old Point) (NASDAQ: OPOF) reported net income of $990 thousand and Read more...

Have we reached a tipping point with stem cell therapy?

TiGenix NV (NYSE Euronext: TIG) is a leading European cell therapy company with an advanced clinical stage pipeline of adult stem cell programmes, and a commercialised product. during Biotech And Mon...

How sickle cell anemia influences a medical school journey

“Where there is no struggle, there is no compassion.” -Frederick Douglass Growing up with sickle cell anemia exposed me to the field of medicine. As I go through the pain and complications, it hum...

Sickle cell is my neighbor

I was diagnosed with sickle cell disease at three months old in Haiti. The diagnosis from the doctor was followed by more tragic news; my parents were told that I was not going to live past five month...

20182023 UK Load Cell Market Report Status and Outlook [Report Updated: 15062018] Prices from USD $3360

In 2017, the Load Cell market size was xx million USD in UK, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In UK market, the top players include ZEMIC Spectris ...

20182023 Philippines Load Cell Market Report Status and Outlook [Report Updated: 15062018] Prices from USD $3360

In 2017, the Load Cell market size was xx million USD in Philippines, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In Philippines market, the top players include ...

20182023 India Load Cell Market Report Status and Outlook [Report Updated: 15062018] Prices from USD $3360

In 2017, the Load Cell market size was xx million USD in India, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023.In India market, the top players include ZEMIC Spe...

Drugs and Medications [130 Associated Drugs and Medications listed on BioPortfolio]

Everyday clean dandruff [On-Point, Inc]

Drug Facts

Cold spot [Pure Source]

Cold Spot Point Relief Pain relieving Gel - 32 oz.

Ibuprofen [Preferred Pharmaceuticals, Inc]

IBUPROFEN

Motrin®ibuprofen tablets, usp [Pharmacia & Upjohn Company]

Motrin®Ibuprofen Tablets, USP

Cold spot [Pure Source]

Cold Spot Point Relief Pain relieving Spray - 16 oz. Spray

PubMed Articles [3226 Associated PubMed Articles listed on BioPortfolio]

Establishment and characterization of immortalized erythroid progenitor cell lines derived from a common cell source.

Immortalized erythroid progenitor cell lines, which exhibit potential for enucleated red blood cell (RBC) production, are expected to serve as an in vitro source of RBCs. These erythroid progenitor ce...

Point-of-Care Screening for Sickle-Cell Disease in Low-Resource Settings: a Multi-Center Evaluation of HemoTypeSC, a Novel Rapid Test.

Sickle cell disease is a common, life-threatening genetic disorder that is best managed when diagnosed early by newborn screening. However, sickle cell disease is most prevalent in low-resource region...

A new standard metric describing the adsorption capacity of carbon electrode used in membrane capacitive deionization.

A new standard metric has been developed to express the actual adsorption capacity of the carbon electrode in consideration of the electrode reactions. The adsorption experiments were carried out by c...

Terahertz communication windows and their point-to-point transmission verification.

Terahertz communication is recognized as a transformational technology that can meet the future demands of point-to-point communication. The study of terahertz atmospheric transmission characteristics...

Excessive outlier removal may result in cut points that are not suitable for immunogenicity assessments.

Cut point determination is an important aspect of immunogenicity assay development. The cut point can be influenced by a myriad of factors. Key among those is the analytical variability of the assay i...

Clinical Trials [7683 Associated Clinical Trials listed on BioPortfolio]

Evaluation of HemoTypeSC as a Novel Rapid Test for Point-of-Care Screening for Sickle-Cell Disease, Hemoglobin C Disease, and Carrier Status in Low-Resource Settings

Sickle cell disease is a life-threatening genetic disorder that can be effectively treated following early diagnosis via newborn screening. However, sickle cell disease is most prevalent i...

Weight Set-Point and HDL Concentration in Runners

To investigate the differences in diet, fat cell morphology and lipoprotein metabolism in previously- overweight and naturally lean men and women who ran and who lived sedentary lifestyles...

Localization of Point A in Cervical Cancer

Point A, the major critical point for dose specification of intracavitary brachytherapy, is defined as the crossing of uterine artery and ureter in treatment of cervical cancer. However, t...

F-Point Validation Study

The F-Point investigation is an open label, single centre prospective observational study in 3 cohorts of patients, one with low fibrinogen concentration, one with normal fibrinogen concen...

A Trial of Point of Care Information in Ambulatory Pediatrics

Does presentation of clinical evidence for decision making at point-of-care improve prescribing patterns in ambulatory pediatrics?

Companies [1484 Associated Companies listed on BioPortfolio]

Cell>Point

Cell>Point is a clinical-stage biopharmaceutical company developing universal molecular imaging agents and molecular therapeutics for the diagnosis, treatment and treatment monito...

Point Foundation

Point Foundation (Point) is the nation's largest scholarship-granting organization for lesbian, gay, bisexual and transgender (LGBT) students of merit. Point provides financial support, leadership tra...

Elsevier and Cell Press

Cell Press, an imprint of Elsevier, is committed to improving scientific communication through the publication of exciting research and reviews. Each of our titles is viewed as a must-read by the ...

Tipping Point Community

Tipping Point Community screens non-profits rigorously to find the most effective groups connecting Bay Area individuals and families to the services and opportunities needed to break the cycle of pov...

BridgeWave Communications

BridgeWave Communications is the leading supplier of high-capacity 4G millimeter wave backhaul and gigabit wireless connectivity solutions. BridgeWave's carrier-grade, point-to-po...

More Information about "Cell>Point" on BioPortfolio

We have published hundreds of Cell>Point news stories on BioPortfolio along with dozens of Cell>Point Clinical Trials and PubMed Articles about Cell>Point for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cell>Point Companies in our database. You can also find out about relevant Cell>Point Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record